Koyfin Home > Directory > Health Care > Acorda Therapeutics > Enterprise Value

Acorda Therapeutics Enterprise Value Chart (ACOR)

Acorda Therapeutics annual/quarterly Enterprise Value from 2010 to 2020.
  • Acorda Therapeutics Enterprise Value for the quarter ending September 09, 2020 was $212m a -1.42% decrease of -3m year over year
  • Acorda Therapeutics Enterprise Value for the last 12 months ending September 09, 2020 was $212m a -1.42% decrease of -3m year over year
  • Acorda Therapeutics Annual Enterprise Value for 2020 was $212m a 0.00% decrease of 0m from 2019
  • Acorda Therapeutics Annual Enterprise Value for 2020 was $212m a -0.51% decrease of -1m from 2019
  • Acorda Therapeutics Annual Enterprise Value for 2020 was $213m a -0.91% decrease of -2m from 2019
Other Valuation Metrics:
  • Acorda Therapeutics Market Cap for the quarter ending March 03, 2018 was $1,110m a 17.15% increase of 190m year over year
  • Acorda Therapeutics Price / Book for the quarter ending March 03, 2018 was 2.11 a 35.48% increase of 0.75 year over year
View Chart On Koyfin

Quarterly ACOR Enterprise Value Data

09/2020$212m
09/2020$212m
09/2020$213m
09/2020$215m
09/2020$213m
09/2020$211m
09/2020$209m
09/2020$209m
09/2020$210m
09/2020$209m

Annual ACOR Enterprise Value Data

2020$212m
2020$212m
2020$213m
2020$215m
2020$213m
2020$211m
2020$209m
2020$209m
2020$210m
2020$209m